论文部分内容阅读
目的：比较不卧床持续腹膜透析（ＣＡＰＤ）和血液透析（血透）治疗终末期肾功能衰竭（肾衰）的疗效及并发症。方法：对１５０例行血透和１４２例使用Ｏ型管（Ｏｓｅｔ）组行ＣＡＰＤ的终末期肾衰病人进行比较。结果：尽管ＣＡＰＤ组老年病人、伴严重心脑血管病及糖尿病的比例高于血透组，但ＣＡＰＤ组的１年和３年生存率与血透组比较无显著性差异（分别为９２％、９０％；８１％、７９％，Ｐ＞０．０５），ＣＡＰＤ病人平均９７．２个病人月发生１次腹膜炎。结论：ＣＡＰＤ是治疗终末期肾衰的理想有效方法，Ｏ型管组对提高ＣＡＰＤ质量很有帮助
Objective: To compare the efficacy and complications of ambulatory peritoneal dialysis (CAPD) and hemodialysis (hemodialysis) in the treatment of end-stage renal failure (renal failure). Methods: 150 patients with hemodialysis and 142 patients with end-stage renal failure who underwent CAPD with Oset were compared. RESULTS: Although the proportion of elderly patients with severe cardiovascular and cerebrovascular disease and diabetes mellitus was significantly higher in the CAPD group than in the hemodialysis group, the 1-year and 3-year survival rates in the CAPD group were not significantly different from those in the hemodialysis group (92% 90%; 81%, 79%, P> 0.05). The average number of patients with CAPD was97.2patients with peritonitis. Conclusion: CAPD is an ideal and effective method for the treatment of end-stage renal failure. O-tube group is helpful to improve the quality of CAPD